U.S. Adds Merck Pill As 2nd Easy-To-Use Drug Against COVID-19

Regulators have authorized an antiviral drug from Merck known as molnupiravir that may help blunt the wave of infections driven by the omicron variant.Regulators have authorized an antiviral drug from Merck known as molnupiravir that may help blunt the wave of infections driven by the omicron variant.Read More